$7 Million Bet on Anti-Aging: YIYUAN Longevity's Ambitious Plans

Nobody saw this coming: a startup in Shenzhen has just raised $5-7 million in angel funding to revolutionize the fragmented and often dubious anti-aging industry. YIYUAN Longevity (Shenzhen) Co., Ltd., co-led by Jianwei Investment and Jingzhi Capital, is staking its claim on a market rife with skepticism by introducing a rigorously scientific approach to longevity and health improvement.

The company is not just another player in the wellness space; it aims to establish a quantifiable, actionable, and verifiable health framework. The anti-aging market has long been marred by a lack of trust, with services that are often more hype than substance. YIYUAN's ambitious goal is to change that narrative by offering a four-step longevity methodology that includes scientific testing, personalized recommendations, intervention execution, and ongoing monitoring and optimization.

At the heart of YIYUAN's offering is a cutting-edge intelligent micro-pressure oxygen-enriched chamber, designed to enhance mitochondrial function and overall health. This innovative device allows users to benefit from scientifically backed interventions that promise to slow down the aging process. The company’s approach is holistic, as it adopts a “1+N” lifecycle service model. Each client is assigned a dedicated health consultant and is connected to a global network of medical and scientific experts. This model aims to provide a comprehensive support system that maximizes the effectiveness of the interventions.

Founder Zhang Kun, who brings a decade of experience in life sciences venture investing to the table, asserts that this expertise forms the backbone of YIYUAN’s trusted and scalable longevity service system. “We understand the industry value chain comprehensively,” he says, hinting at a well-thought-out strategy to navigate a market that has been historically difficult to penetrate due to trust issues. With this round of funding, YIYUAN plans to expand its team and accelerate research and development in longevity technology, positioning itself for future growth.

The longevity sector is increasingly attracting attention and investment, with major players scrambling to differentiate themselves in a crowded marketplace. According to a recent report, the global anti-aging market is expected to reach $421 billion by 2030, driven by rising consumer awareness and demand for health and wellness products. YIYUAN's data-driven approach may well give it an edge in this burgeoning landscape.

Meanwhile, on another front in China's tech scene, Dreame Technology has been making headlines of its own. Announced on January 21, 2026, the company has been named the Intelligent Technology Ecosystem Strategic Partner of the 2026 CCTV Spring Festival Gala. This prestigious collaboration underscores Dreame's commitment to integrating advanced technology into everyday life, spanning sectors like intelligent cleaning, home appliances, and more.

Dreame serves over 42 million households globally, with multiple business lines ranking among the top three in their respective categories. The partnership with CCTV is expected to significantly enhance Dreame's brand visibility and support its ongoing global expansion efforts. The Spring Festival Gala is one of the most-watched television events in the world, presenting Dreame with an unparalleled opportunity to showcase its technological capabilities to a massive audience.

As both YIYUAN Longevity and Dreame Technology position themselves at the forefront of their respective industries, their endeavors reflect a broader trend in China: a push towards innovation and scientific rigor in markets that have often been characterized by ambiguity and skepticism. Investors and consumers alike are watching closely, eager to see which companies will emerge as the leaders in this new era of health and technology.

The stakes are high, and the potential rewards are enormous. As the anti-aging market continues to evolve, YIYUAN Longevity's scientifically grounded approach may just be the key to unlocking a future where health and longevity are quantifiable and accessible to all.